Cannlabs (OTCMKTS:CANL – Get Free Report) and HealthEquity (NASDAQ:HQY – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, dividends, valuation and analyst recommendations.
Profitability
This table compares Cannlabs and HealthEquity’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Cannlabs | N/A | N/A | N/A |
HealthEquity | 11.49% | 12.04% | 7.44% |
Volatility and Risk
Cannlabs has a beta of 1.59, indicating that its share price is 59% more volatile than the S&P 500. Comparatively, HealthEquity has a beta of 0.47, indicating that its share price is 53% less volatile than the S&P 500.
Analyst Recommendations
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Cannlabs | 0 | 0 | 0 | 0 | 0.00 |
HealthEquity | 0 | 2 | 11 | 1 | 2.93 |
HealthEquity has a consensus price target of $121.31, indicating a potential upside of 33.25%. Given HealthEquity’s stronger consensus rating and higher probable upside, analysts plainly believe HealthEquity is more favorable than Cannlabs.
Institutional & Insider Ownership
99.6% of HealthEquity shares are held by institutional investors. 1.5% of HealthEquity shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Valuation and Earnings
This table compares Cannlabs and HealthEquity”s top-line revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Cannlabs | N/A | N/A | N/A | N/A | N/A |
HealthEquity | $1.20 billion | 6.54 | $96.70 million | $1.65 | 55.18 |
HealthEquity has higher revenue and earnings than Cannlabs.
Summary
HealthEquity beats Cannlabs on 10 of the 11 factors compared between the two stocks.
About Cannlabs
CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing. The company also offers data/analytics and consulting, as well as education services. CannLabs, Inc. was incorporated in 2010 and is based in Denver, Colorado.
About HealthEquity
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.
Receive News & Ratings for Cannlabs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cannlabs and related companies with MarketBeat.com's FREE daily email newsletter.